Detalhe da pesquisa
1.
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
Oncologist
; 29(5): 450-e725, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452035
2.
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
BMC Cancer
; 24(1): 493, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637770
3.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
4.
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist
; 28(8): 737-e693, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952231
5.
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
Oncologist
; 28(4): 333-340, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576173
6.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909949
7.
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.
J Natl Compr Canc Netw
; 19(9): 1006-1019, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551388
8.
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Cancer
; 126(11): 2597-2606, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208524
9.
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions.
BJU Int
; 125(5): 739-746, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985116
10.
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Cancer
; 125(4): 533-540, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570744
11.
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.
Lancet Oncol
; 19(4): 451-460, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29530667
12.
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Cancer
; 124(10): 2115-2124, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29517810
13.
Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.
Invest New Drugs
; 34(2): 243-52, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26897615
14.
Superstition predicts favorable weight change in an open-placebo trial: a prospective study.
Eat Weight Disord
; 20(3): 389-95, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416546
15.
Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance.
Urol Oncol
; 42(7): 193-202, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341364
16.
Predictors of response to neoadjuvant therapy in urothelial cancer.
Crit Rev Oncol Hematol
; 194: 104236, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128631
17.
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
JAMA Netw Open
; 7(5): e249417, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696168
18.
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
J Clin Oncol
; 42(12): 1415-1425, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261969
19.
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE).
BMC Res Notes
; 16(1): 16, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797744
20.
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations.
JCO Precis Oncol
; 7: e2300095, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410974